The stock of CryoPort Inc (CYRX) has gone down by -14.01% for the week, with a -9.10% drop in the past month and a 7.31% rise in the past quarter. The volatility ratio for the week is 7.70%, and the volatility levels for the past 30 days are 7.33% for CYRX. The simple moving average for the past 20 days is -6.93% for CYRX’s stock, with a -22.54% simple moving average for the past 200 days.
Is It Worth Investing in CryoPort Inc (NASDAQ: CYRX) Right Now?
The 36-month beta value for CYRX is at 1.58. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 2 rating it as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for CYRX is 47.59M, and currently, shorts hold a 4.36% of that float. The average trading volume for CYRX on January 15, 2025 was 384.74K shares.
CYRX) stock’s latest price update
The stock price of CryoPort Inc (NASDAQ: CYRX) has dropped by -10.73 compared to previous close of 8.39. Despite this, the company has seen a fall of -14.01% in its stock price over the last five trading days. prnewswire.com reported 2025-01-14 that Cryoport’s CRYOGENE will provide Moffitt with state-of-the-art biorepository services TAMPA, Fla. and NASHVILLE, Tenn.
Analysts’ Opinion of CYRX
Many brokerage firms have already submitted their reports for CYRX stocks, with Guggenheim repeating the rating for CYRX by listing it as a “Buy.” The predicted price for CYRX in the upcoming period, according to Guggenheim is $11 based on the research report published on December 19, 2024 of the previous year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see CYRX reach a price target of $8, previously predicting the price at $20. The rating they have provided for CYRX stocks is “Hold” according to the report published on August 07th, 2024.
B. Riley Securities gave a rating of “Buy” to CYRX, setting the target price at $15 in the report published on July 31st of the previous year.
CYRX Trading at -2.39% from the 50-Day Moving Average
After a stumble in the market that brought CYRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.75% of loss for the given period.
Volatility was left at 7.33%, however, over the last 30 days, the volatility rate increased by 7.70%, as shares sank -4.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.99% upper at present.
During the last 5 trading sessions, CYRX fell by -14.01%, which changed the moving average for the period of 200-days by -58.66% in comparison to the 20-day moving average, which settled at $8.05. In addition, CryoPort Inc saw -3.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CYRX starting from Mandalam Ramkumar, who sale 7,369 shares at the price of $7.46 back on Dec 02 ’24. After this action, Mandalam Ramkumar now owns 59,497 shares of CryoPort Inc, valued at $54,978 using the latest closing price.
Hariri Robert J, the Director of CryoPort Inc, sale 2,500 shares at $6.48 during a trade that took place back on Nov 21 ’24, which means that Hariri Robert J is holding 20,561 shares at $16,200 based on the most recent closing price.
Stock Fundamentals for CYRX
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.38 for the gross margin
The net margin for CryoPort Inc stands at -0.7. The total capital return value is set at -0.11. Equity return is now at value -33.15, with -18.62 for asset returns.
Based on CryoPort Inc (CYRX), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at -0.04. The debt to equity ratio resting at 0.56. The interest coverage ratio of the stock is -15.13.
Currently, EBITDA for the company is -66.36 million with net debt to EBITDA at -1.53. When we switch over and look at the enterprise to sales, we see a ratio of 2.47. The receivables turnover for the company is 5.2for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.70.
Conclusion
In conclusion, CryoPort Inc (CYRX) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
